参考文献/References:
[1]Phuah CL,Chen Y,Strain JF,et al.Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies[J].Neurology,2022,99(23):e2535-e2547.[2]Wang YJ,Li ZX,Gu HQ,et al.China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations[J].Stroke Vasc Neurol,2022,7(5):415-450.[3]Xu W,Huang J,Yu Q,et al.A systematic review of the status and methodological considerations for estimating risk of first ever stroke in the general population[J].Neurol Sci,2021,42(6):2235-2247.[4]GBD 2019 Stroke Collaborators.Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet Neurol,2021,20(10):795-820.[5]Rong X,Chen J,Pan D,et al.Association between Apolipoprotein E genotype and functional outcome in acute ischemic stroke[J].Aging (Albany NY),2023,15(1):108-118.[6]Hostettler IC,Seiffge D,Wong A,et al.APOE and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage[J].Neurology,2022,99(12):e1290-e1298.[7]张立,王托弟,黄旌,等.蛛网膜下腔出血大鼠脑组织载脂蛋白E的表达升高[J].神经损伤与功能重建,2022,17(3):152-154.[8]Rannikm?覿e K,Kalaria RN,Greenberg SM,et al.APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis[J].J Neurol Neurosurg Psychiatry,2014,85(3):300-305.[9]Bi Q,Zhou X,Lu Y,et al.Polymorphisms of the apolipoprotein E gene affect response to atorvastatin therapy in acute ischemic stroke[J].Front Cardiovasc Med,2022,9:1024014.[10]Kloske CM,Barnum CJ,Batista AF,et al.APOE and immunity: Research highlights[J].Alzheimers Dement,2023,19(6):2677-2696.[11]Nakamura T,Kawarabayashi T,Ueda T,et al.Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer’s Disease[J].J Alzheimers Dis,2023,93(1):333-348.[12]Tréguier Y,Bull-Maurer A,Roingeard P.Apolipoprotein E, a Crucial Cellular Protein in the Lifecycle of Hepatitis Viruses[J].Int J Mol Sci,2022,23(7):3676.[13]Mahley RW,Rall SC Jr.Apolipoprotein E: far more than a lipid transport protein[J].Annu Rev Genomics Hum Genet,2000,1:507-537.[14]Fernández-Calle R,Konings SC,Fronti?觡án-Rubio J,et al.APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases[J].Mol Neurodegener,2022,17(1):62.[15]孔咏梅,郭医杰,王美蓉,等.ApoE基因多态性与脑梗死认知障碍及复发的相关性分析[J].湖南师范大学学报(医学版),2021,18(3):178-181.[16]杜艳梅,田展松,李红,等.ApoE基因多态性、Hcy与2型糖尿病患者发生冠状动脉粥样硬化性心脏病的相关性研究[J].空军军医大学学报,2023,44(8):717-720.[17]Wen B,Dang YY,Wu SH,et al.Antiatherosclerotic effect of dehydrocorydaline on ApoE-/- mice: inhibition of macrophage inflammation[J].Acta Pharmacol Sin,2022,43(6):1408-1418.[18]de Leeuw SM,Kirschner AWT,Lindner K,et al.APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes[J].Stem Cell Reports,2022,17(1):110-126.[19]Liu K,Chen B,Zeng F,et al.ApoE/NOS3 Knockout Mice as a Novel Cardiovascular Disease Model of Hypertension and Atherosclerosis[J].Genes (Basel),2022,13(11):1998.[20]Marais AD.Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease[J].Pathology,2019,51(2):165-176.[21]Hoogeveen RC,Ballantyne CM.Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation[J].Clin Chem,2021,67(1):143-153.[22]Navarese EP,Robinson JG,Kowalewski M,et al.Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis [J].JAMA,2018,319(15):1566-1579.[23]Kim JS,Han SR,Chung SW,et al.The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease[J].J Neurol Sci,2003,206(1):31-37.[24]Konialis C,Spengos K,Iliopoulos P,et al.The APOE E4 Allele Confers Increased Risk of Ischemic Stroke Among Greek Carriers[J].Adv Clin Exp Med,2016,25(3):471-478.[25]王辉.ApoE基因多态性与缺血性脑卒中的相关性研究[D].苏州:苏州大学,2019.[26]Marais AD.Apolipoprotein E and Atherosclerosis[J].Curr Atheroscler Rep,2021,23(7):34.[27]Ferrucci L,Guralnik JM,Pahor M,et al.Apolipoprotein E epsilon 2 allele and risk of stroke in the older population[J].Stroke,1997,28(12):2410-2416.[28]张波,张卓伯,刘洪,等.载脂蛋白E基因多态性与脑梗塞的关联研究[J].华西医学,2006(1):90-91.[29]陆小林,林志伟,陈丽芳,等.ApoE基因多态性与动脉粥样硬化性脑梗死的相关性研究[J].中国实用神经疾病杂志,2018,21(22):2463-2469.[30]Granér M,Kahri J,Varpula M,et al.Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease[J].Nutr Metab Cardiovasc Dis,2008,18(4):271-277.[31]Khan TA,Shah T,Prieto D,et al.Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals[J].Int J Epidemiol,2013,42(2):475-492.[32]Patrick RP.Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer’s disease[J].FASEB J,2019,33(2):1554-1564.[33]周君,于富敏,李晓霞.载脂蛋白E基因多态性与脑梗死的关系[J].中国脑血管病杂志,2006(6):263-266.[34]Sheth KN.Spontaneous Intracerebral Hemorrhage[J].N Engl J Med,2022,387(17):1589-1596.[35]Tsao CW,Aday AW,Almarzooq ZI,et al.Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association[J].Circulation,2022,145(8):e153-e639.[36]Broderick J,Connolly S,Feldmann E,et al.Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group[J].Stroke,2007,38(6):2001-2023.[37]Peck G,Smeeth L,Whittaker J,et al.The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults[J].PLoS One,2008,3(11):e3691.[38]Devan WJ,Falcone GJ,Anderson CD,et al.Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage[J].Stroke,2013,44(6):1578-1583.[39]Brouwers HB,Biffi A,Ayres AM,et al.Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage[J].Stroke,2012,43(6):1490-1495.[40]Raffeld MR,Biffi A,Battey TW,et al.APOE ε4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage[J].Neurology,2015,85(4):349-356.[41]Sawyer RP,Sekar P,Osborne J,et al.Racial/ethnic variation of APOE alleles for lobar intracerebral hemorrhage[J].Neurology,2018,91(5):e410-e420.[42]Nie H,Hu Y,Liu N,et al.Apolipoprotein E Gene Polymorphisms Are Risk Factors for Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-analysis[J].Curr Med Sci,2019,39(1):111-117.[43]Ferreira CN,Carvalho MG,Fernandes AP,et al.Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders[J].Neurochem Int,2010,56(1):177-182.[44]Phuah CL,Raffeld MR,Ayres AM,et al.APOE polymorphisms influence longitudinal lipid trends preceding intracerebral hemorrhage[J].Neurol Genet,2016,2(4):e81.[45]Nunes VS,da Silva Ferreira G,Quint?觔o ECR.Cholesterol metabolism in aging simultaneously altered in liver and nervous system[J].Aging (Albany NY),2022,14(3):1549-1561.[46]Wang X,Dong Y,Qi X,et al.Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis[J].Stroke,2013,44(7):1833-1839.[47]Suzuki K,Izumi M,Sakamoto T,et al.Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan[J].Cerebrovasc Dis,2011,31(1):100-106.[48]Yu Z,Zhang L,Zhang G,et al.Lipids, Apolipoproteins, Statins, and Intracerebral Hemorrhage: A Mendelian Randomization Study[J].Ann Neurol,2022,92(3):390-399.[49]Charidimou A,Boulouis G,Frosch MP,et al.The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study[J].Lancet Neurol,2022,21(8):714-725.[50]Pasi M,Sugita L,Xiong L,et al.Association of Cerebral Small Vessel Disease and Cognitive Decline After Intracerebral Hemorrhage[J].Neurology,2021,96(2):e182-e192.[51]Esiri M,Chance S,Joachim C,et al.Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA[J].Brain Pathol,2015,25(1):51-62.[52]Koutsodendris N,Nelson MR,Rao A,et al.Apolipoprotein E and Alzheimer’s Disease: Findings, Hypotheses, and Potential Mechanisms[J].Annu Rev Pathol,2022,17:73-99.[53]Nelson PT,Pious NM,Jicha GA,et al.APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature[J].J Neuropathol Exp Neurol,2013,72(7):708-715.[54]Charidimou A,Zonneveld HI,Shams S,et al.APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms[J].Neurology,2019,93(4):e358-e371.[55]Weisgraber KH,Innerarity TL,Mahley RW.Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site[J].J Biol Chem,1982,257(5):2518-2521.[56]Ye X,Jia Y,Song G,et al.Apolipoprotein E ε2 is Associated with the White Matter Hyperintensity Multispot Pattern in Spontaneous Intracerebral Hemorrhage[J].Transl Stroke Res,2024,15(1):101-109.[57]Li Z,Shue F,Zhao N,et al.APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease[J].Mol Neurodegener,2020,15(1):63.[58]Serrano-Pozo A,Das S,Hyman BT.APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches[J].Lancet Neurol,2021,20(1):68-80.[59]Muhammad S,H?覿nggi D.Inflammation and Anti-Inflammatory Targets after Aneurysmal Subarachnoid Hemorrhage[J].Int J Mol Sci,2021,22(14):7355.[60]Romenskaya T,Longhitano Y,Piccolella F,et al.Cerebral Vasospasm: Practical Review of Diagnosis and Management[J].Rev Recent Clin Trials,2023,18(1):12-18.[61]Niskakangas T,Ohman J,Niemel?覿 M,et al.Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: a preliminary study[J].Stroke,2001,32(5):1181-1184.[62]Gao J,Wang H,Sheng H,et al.A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage[J].Neurocrit Care,2006,4(1):25-31.[63]阮健,谢延风,孙晓川,等.载脂蛋白E基因型多态性与SAH后血管痉挛的相关研究[J].重庆医科大学学报,2010,35(1):79-83.[64]Yin C,Ruan J,Jiang L,et al.The relationship between rebleeding after spontaneous SAH and APOE polymorphisms in a Chinese population[J].Int J Neurosci,2012,122(8):472-476.